Local Treatment With Radical Prostatectomy (RP) for Newly-diagnosed Metastatic Prostate Cancer (mPCa).
Status: Recruiting
Location: See all (5) locations...
Intervention Type: Procedure
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY
The objective of this study is to evaluate the role of local treatment with radical prostatectomy in patients with newly-diagnosed metastatic hormone-sensitive prostate cancer.
Eligibility
Participation Requirements
Sex: Male
Minimum Age: 18
Maximum Age: 85
Healthy Volunteers: f
View:
• Diagnosis of prostate adenocarcinoma, confirmed by histology
• Newly diagnosis of metastatic disease (stage TanyNanyM+)
• Life expectancy ≥2y based on comorbid conditions, WHO performance status 0-2
• Written informed consent, male ≥18yo
• Willing and expected to comply with study protocol and follow-up schedule
• Multidisciplinary Oncologic Consultation (MOC) approval
Locations
Other Locations
Belgium
ASZ Aalst
RECRUITING
Aalst
Imelda Ziekenhuis
RECRUITING
Bonheiden
University Hospital, Ghent
RECRUITING
Ghent
Sint-Fransiskusziekenhuis
RECRUITING
Heusden-zolder
AZ Jan Portaels
RECRUITING
Vilvoorde
Contact Information
Primary
Nicolaas Lumen, MD, PhD
nicolaas.lumen@uzgent.be
Time Frame
Start Date: 2018-06-28
Estimated Completion Date: 2024-12-31
Participants
Target number of participants: 80
Treatments
No_intervention: No local treatment
Routine care in metastatic prostate cancer.
Experimental: Local treatment
Radical Prostatectomy (RP) + routine care in metastatic prostate cancer.
Related Therapeutic Areas
Sponsors
Leads: University Hospital, Ghent